Wiens, Jenna http://orcid.org/0000-0002-1057-7722
Saria, Suchi
Sendak, Mark http://orcid.org/0000-0001-5828-4497
Ghassemi, Marzyeh
Liu, Vincent X.
Doshi-Velez, Finale
Jung, Kenneth
Heller, Katherine
Kale, David
Saeed, Mohammed
Ossorio, Pilar N.
Thadaney-Israni, Sonoo
Goldenberg, Anna
Article History
Received: 10 July 2019
Accepted: 17 July 2019
First Online: 19 August 2019
Change Date: 19 September 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: J.W., F.D.-V., D.K. and K.J. are on the board of Machine Learning for Healthcare, a non-profit organization that hosts a yearly academic meeting; they are reimbursed for registration and travel expenses. F.D.-V. consults for DaVita, a healthcare company. S.T.-I. serves on the board of Scients (ExternalRef removed) and is reimbursed for travel expenses. S.S. is a founder of, and holds equity in, Bayesian Health. The results of the study discussed in this publication could affect the value of Bayesian Health. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict-of-interest policies. S.S. is a member of the scientific advisory board for PatientPing. M. Sendak is a named inventor of the Sepsis Watch deep-learning model, which was licensed from Duke University by Cohere Med, Inc. M. Sendak does not hold any equity in Cohere Med, Inc. M. Saeed is a founder and Chief Medical Officer at HEALTH at SCALE Technologies and holds equity in this company. P.O. consults for Roche-Genentech, from whom she has received travel reimbursement and consulting fees of less than $4,000/year. A.G., K.H., M.G. and V.L. have no conflicts to declare.